Company / R&D per Share
CAPRICOR THERAPEUTICS, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.47
FY2025
5-year range
$0.56 / $1.47
FY2021-FY2025
Trend
+34.3%
vs FY2024
Sector context
#124 of 208
Health Care
What the data says
At $1.47, CAPRICOR THERAPEUTICS, INC.'s r&d per share ranks #124 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.38 in FY2018 to $3.84 in FY2019.
Based on SEC 10-K filings.
1.47 in FY2025 with a 5-year CAGR of +29.1%.
Improved from $1.17 to $1.47 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +19.4%
- 5-Year CAGR
- +29.1%
- 10-Year CAGR
- -
Sector benchmark
#124 of 208 in Health CareTop 60% of 208This company $1.47 Sector average $28.77
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 34.3% year-over-year.
- Ranks #124 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.47 | +34.3% |
| FY2024 | $1.10 | -6.3% |
| FY2023 | $1.17 | +35.4% |
| FY2022 | $0.86 | +54.0% |
| FY2021 | $0.56 | +36.5% |
| FY2020 | $0.41 | -89.3% |
| FY2019 | $3.84 | +900.0% |
| FY2018 | $0.38 | -6.2% |
| FY2017 | $0.41 | -45.3% |
| FY2016 | $0.75 | -11.4% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026